Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Bhavana Pothuri, Sileny Han, Dana M. Chase, Florian Heitz, Robert A. Burger, Lydia Gaba, Linda Van Le, Eva Guerra, David Bender, Jacob Korach, Noelle Cloven, Cristina Churruca, Philippe Follana, Paul DiSilvestro, Jean François Baurain, Kris Jardon, Carmela Pisano, Ulla Peen, Johanna Mäenpää, Divya GuptaEmeline Bacqué, Yong Li, Natalie Compton, Jenya Antonova, Bradley J. Monk, Antonio González-Martín
Research output: Contribution to journal › Article › Scientific › peer-review
5Citations
(Scopus)
10Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial'. Together they form a unique fingerprint.